Product Images Venlafaxine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 50090-5929 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 01

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 01

The text provides a list of drugs that interact with Ethanol in individuals who have CYP2D6 enzyme extensive metabolizer and poor metabolizer phenotype. Ketoconazole, diazepam, and cimetidine are some of the drugs that interact with Ethanol in extensive metabolizers, while indinavir, metoprolol, imipramine, and lithium interact with Ethanol in poor metabolizers. The text also contains information on venlafaxine's analytical properties and PK fold change recommendations based on Cmax and AUC values. There are recommendations for dose adjustment and use with caution, especially in patients with hypertension, elderly or hepatic dysfunction, and monitoring of blood pressure.*

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 02

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 02

This is a list of drugs and their interaction with other drugs. The list includes drugs such as Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, and Lithium. The table also shows the Analyte PKFold Change and 90% CRecommendation. The Cmax value is provided for different drugs indicating the level of dose adjustment or restriction to be followed while taking them. However, some of the information is not available due to errors.*

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 03

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 03

This is a drug dosage recommendation guide for individuals with different health conditions, such as hepatic impairment, renal impairment, age, gender, and CYP2D8 polymorphism, for the drug analyte venlafaxine. The guide recommends reducing the dose by 50% or greater for individuals with hepatic impairment and increasing individualized dosing for other conditions such as mild/moderate impairment (renal), age (> 80 years), and CYP2D8 polymorphism, wherein no dose adjustment is recommended for others. The guide also provides fold change and 90% confidence intervals in the PK (pharmacokinetics) of the drug.*

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 04

Venlafaxine hydrochloride extended-release capsules, USP - 310c558f 5135 4ddd b0bd f993c0ea8d62 04

The text contains two different parts that are not related to each other. The first part includes the text "eHCI" and "H4C0 C" which are not identifiable words and might be a code or abbreviation of some sort. The second part indicates the name of a medication which is "venlafaxine hydrochloride."*

Label Image - lbl500905929

Label Image - lbl500905929

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.